Last updated 13 months ago

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

740 patients around the world
Available in Argentina
Tesaro, Inc.
3Research sites
740Patients around the world
This study is for people with
Solid tumors
Lung cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
CEMER Centro Médico de Enfermedades Respiratorias - Vicente Lopez
Recruiting
Esmeralda 1550, Vicente Lopez, Buenos Aires
Clínica Universitaria Privada Reina Fabiola - Córdoba
Recruiting
Oncativo 1248, X5004FHP Córdoba, Argentina
Instituto Oncológico de Córdoba IONC - Fundación Richardet Longo
Recruiting
Paraná 560, Córdoba
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy